RxDoctor Payments Data

Brent Wilson, MD

Emergency Medicine · Fresno, CANPI 1184647091

Payments from drug & device makers

$786in general payments, 2019–2025

Across 38 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$283
  • Lilly USA, LLC$151
  • Amgen$63
  • Pfizer$54
  • Vertex$35
  • Lundbeck LLC$33
  • plus $165 from 7 others

What the payments were for

  • Food & beverage$786100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$786 in reported general payments places this provider in the 90th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California

Medicare billing

Part B allowed, 2024
$349,544
Medicare patients
443
Services billed
5,914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin63$47,683
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$36,415
EliquisApixaban43$30,291
JanuviaSitagliptin Phosphate28$19,646
TradjentaLinagliptin28$17,061
MyrbetriqMirabegron25$16,024
RybelsusSemaglutide11$13,859
Breo ElliptaFluticasone/Vilanterol26$10,950
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen258$5,276
Albuterol Sulfate HfaAlbuterol Sulfate82$2,682
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,611
Atorvastatin Calcium255$2,177
Metoprolol Succinate112$2,074
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm15$1,942
Ventolin HfaAlbuterol Sulfate25$1,931

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$54$30,29143 claims
Novo NordiskRybelsus$23$13,85911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,006 emergency medicine providers in California.

Other emergency medicine in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →